Skip to main content
. Author manuscript; available in PMC: 2021 Dec 22.
Published in final edited form as: Transplantation. 2020 Jun;104(6):1287–1293. doi: 10.1097/TP.0000000000002960

Table 1:

Study Population

SPK patient characteristics Pancreas graft survival ≥ 25 years at last follow up Pancreas graft survival <25 years at last follow up p
Total number of patients 39 244
Year of transplant (range) 1986–1993 1986–1993
Mean age at transplant (years) 35.0 ± 6.1 35.4 ± 5.9 0.67
Male 22 (56.4%) 151 (61.8%) 0.51
Race: 0.49
Caucasian 39 (100%) 241 (98.7%)
Bladder drained pancreas duct 38 (97.4%) 225 (92.2%) 0.24
Induction immunosuppressive medication 0.86
Minnesota anti-lymphocyte globulin (MALG) 7 (17.9%) 41 (16.8%)
OKT3 32 (82%) 203 (83.1%)
Pancreas graft outcomes: All functional
Death with functional graft 90 (36.7%)
Resumption of moderate- to high-dose insulin 97 (39.6%)
Graft removed 29 (11.8%)
Other (Transferred to a different center, death with unknown pancreas graft function) 29 (11.8%)
Mean pancreas graft survival at last follow up (years) 27.5 ± 1.9 9.8 ± 7.5 <0.001